Nambling, Al .
HRN: 25-27-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2024
CEFTRIAXONE 1G (VIAL)
06/10/2024
06/17/2024
IV
1G
Q12hrs
EPIGLOTTITIS
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes